- Home
- GLST vs FBIO Comparison
GLST vs FBIO Comparison
Compare GLST & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLST
- FBIO
- Stock Information
- Founded
- GLST 2019
- FBIO 2006
- Country
- GLST United States
- FBIO United States
- Employees
- GLST N/A
- FBIO N/A
- Industry
- GLST Consumer Electronics/Appliances
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GLST Industrials
- FBIO Health Care
- Exchange
- GLST Nasdaq
- FBIO Nasdaq
- Market Cap
- GLST 48.0M
- FBIO 39.4M
- IPO Year
- GLST 2022
- FBIO N/A
- Fundamental
- Price
- GLST $6.47
- FBIO $1.62
- Analyst Decision
- GLST
- FBIO Strong Buy
- Analyst Count
- GLST 0
- FBIO 3
- Target Price
- GLST N/A
- FBIO $18.00
- AVG Volume (30 Days)
- GLST 17.2K
- FBIO 273.9K
- Earning Date
- GLST 01-01-0001
- FBIO 03-27-2025
- Dividend Yield
- GLST N/A
- FBIO N/A
- EPS Growth
- GLST N/A
- FBIO N/A
- EPS
- GLST N/A
- FBIO N/A
- Revenue
- GLST N/A
- FBIO $81,501,000.00
- Revenue This Year
- GLST N/A
- FBIO N/A
- Revenue Next Year
- GLST N/A
- FBIO $128.63
- P/E Ratio
- GLST N/A
- FBIO N/A
- Revenue Growth
- GLST N/A
- FBIO 31.51
- 52 Week Low
- GLST $6.04
- FBIO $1.36
- 52 Week High
- GLST $20.89
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- GLST 35.16
- FBIO 33.40
- Support Level
- GLST $7.83
- FBIO $1.65
- Resistance Level
- GLST $20.89
- FBIO $1.85
- Average True Range (ATR)
- GLST 3.10
- FBIO 0.10
- MACD
- GLST -0.36
- FBIO -0.01
- Stochastic Oscillator
- GLST 2.89
- FBIO 7.32
About GLST Global Star Acquisition Inc.
Global Star Acquisition Inc is a blank check company.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.